Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by bradykinesia, rigidity, and tremor. Considerable progress has been made to understand the …
W Wang, X Wang, W Gao, Z Cui, H Zhang, F Lu… - International Journal of …, 2022 - Elsevier
Misfolding and aggregation of α-synuclein (α-syn) play a key role in the pathogenesis of Parkinson's disease (PD). Herein, the inhibitory effect of ulvan on α-syn fibrillogenesis was …
Klinik Gelişim instabilite, dizartri, palilali, disfaji, fleksör postür, donma gibi) ve tremor üzerine etkisinin sınırlı olduğu bilinmektedir. Bugün için PH tedavisinde ideal bir ilacın varlığından …
A Rewane, P Patel, S Nagalli - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Objectives: Identify the approved indications for ropinirole therapy. Recognize the possible adverse effects of ropinirole. Screen patients for ropinirole therapy based on its …
OME Abdel-Salam - World journal of pharmacology, 2015 - wjgnet.com
Parkinson's disease (PD) is the most common neurodegenerative movement disorder, affecting about 1% of the population above the age of 65. PD is characterized by a selective …
AF Becerra, M Boch, YA Al-Mezrakchi - Cureus, 2021 - ncbi.nlm.nih.gov
Ropinirole is an overall well-tolerated antiparkinsonian medication that is also used to treat restless leg syndrome (RLS). The incidence of side effects is low, with orthostatic …
YC Hwang, J Leem - Journal of Society of Preventive Korean …, 2024 - koreascience.kr
Objectives: This study is to investigate the current National Health Insurance Database cohort studies related to complications of Parkinson's Disease (PD) and suggest the design …
FA Abbasov, MM Yusupova, EV Bril - Medical alphabet, 2022 - med-alphabet.com
Drooling is a common non-motor symptom of Parkinson's disease, affecting about half of patients at different stages of the disease. Drooling can significantly reduce quality of life and …